Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 5, 1997, Pages 1355-1362

  Schultz, Joel J ^a   Hsu, Anna K ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Infarct size; Ischemic preconditioning; Naloxone methiodide; Peripheral opioid receptors; Quaternary compound

Indexed keywords

17 METHYLNALOXONE; NALOXONE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0031148929     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0369     Document Type: Article

References (29)

1. ATWEH SF, KUHAR MJ, 1977. Autoradiographic localization of opiate receptors in rat brain: spinal cord and lower medulla. Brain Res 124: 53-67.
2. BIANCHETTI A, NISATO D, SACILOTTO R, DRAGONETTI M, PICERNO N, TARANTINO A, MANARA L, ANGEL LM, SIMON EJ, 1983. Quaternary derivatives of narcotic antagonists: stereochemical requirements at the chiral nitrogen for in vitro and in vivo activity. Life Sci 33: 415-418.
3. BLUMBERGH H, DAYTON HB, GEORGE M, RAPAPORT DN, 1961. N-allylnoroxymorphone: a potent narcotic antagonist. Fed Proc 20: 311.
4. CHIEN GL, VAN WINKLE DM, 1996. Naloxone blockade of myocardial ischemic preconditioning is stereoselective. J Mol Cell Cardiol 28: 1895-1900.
5. CLEMENT-JONES V, LOWRY P, REES LH, BESSER GM, 1980. Met-enkephalin circulates in human plasma. Nature (London) 283: 295-297.
6. FOLDES FF, LUNN JN, MOORE J, BROWN IM, 1963. N-Allylnoroxymorphone: a potent narcotic antagonist. Am J Med Sci 245: 23-30.
7. GOODMAN RR, SNYDER SH, KUHAR MJ, YOUNG WS III, 1980. Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. Proc Natl Acad Sci USA 77: 6239-6243.
8. GUILLEMIN R, VARGO TM, ROSSIER J, MINICK S, LING N, RIVIER C, 1977. Beta-endorphin and adrenal corticotropin are secreted concomitantly by the pituitary gland. Science 197: 1367-1369.
9. HOKFELT T, ELDE R, JOHANSSON O, TERENIUS L, STEIN L, 1977. The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system. Neurosci Lett 5: 25-31.
10. HOLADAY JW, 1983. Cardiovascular effects of endogenous opiate systems. Ann Rev Pharmacol Toxicol 23: 541-594.
11. JASINSKI DR, MARTIN WR, HAERTZEN CA, 1967. The human pharmacology and abuse potential of N-allylnoroxmorphone (Naloxone). J Pharmacol Exp Ther 157: 420-426.
12. KLEIN HH, PUSCHMANN S, SCHAPER J, SCHAPER W, 1981. The mechanism of the tetrazolium reaction in identifying myocardial infarction. Virchows Arch 393: 287-297.
13. KOSTERLITZ HW, WATEREIELD AA, 1975. In vitro models in the study of structure-activity relationships of narcotic analgesics. Annu Rev Pharmacol Toxicol 15: 29-47.
14. KRUMINS SA, FADEN AI, FEUERSTEIN G, 1985. Opiate binding in rat hearts: modulation of binding after hemorrhagic shock. Biochem Biophys Res Commun 127: 120-128.
15. MARTIN WR, 1984. Pharmacology of opioids. Pharmacol Rev 35: 283-323.
16. MAY CJ, DASHWOOD MR, WHITEHEAD CJ, MATHIAS CJ, 1989. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution. Br J Pharmacol 98: 903-913.
17. MILNE RJ, CODDINGTON JM, GAMBLE GD, 1990. Quaternary naloxone blocks morphine analgesia in spinal but not intact rats. Neurosci Lett 114: 259-264.
18. 3H] naltrexonium methiodide in the rat. J Pharm Pharmacol 39: 225-227.
19. NOTARNICOLA A, LANDI M, BIANCHI G, TAVANI A, 1983. Relative ability of N-methyl nalorphine and N-methyl levallorphan to prevent antinociception and intestinal transit inhibition in morphine treated rats. Life Sci 33: 481-484.
20. QUIRION R, FINKEL MS, MENDELSOHN FA, ZAMIR N, 1983. Localization of opiate binding sites in kidney and adrenal gland of the rat. Life Sci 33: 299-302.
21. PEROUTKA SJ, MOSKOWITZ MA, REINHARD JF JR, SNYDER SH, 1980. Neurotransmitter receptor binding in bovine cerebral microvessels. Science 208: 610-612.
22. RAMIREZ-GONZALEZ MD, TCHAKAROV L, GARCIA RM, KUNOS G, 1983. β-endorphin acting on the brainstem is involved in the antihypertensive action of clonidine and α-methyldopa in rats. Circ Res 53: 150-157.
23. RUSSELL J, BASS P, GOLDBERG LI, SCHUSTER CR, MERZ H, 1982. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists. Eur J Pharmacol 78: 255-261.
24. SCHULTZ JJ, ROSE E, YAO Z, GROSS GJ, 1995. Evidence for opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 268: H2157-H2161.
25. VALENTINO RJ, HERLING S, WOODS JH, MEDZIHRADSKY F, MERZ H, 1981. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists. J Pharmacol Exp Ther 217: 652-659.
26. VENTURA C, BASTAGLI L, BERNARDI P, CALDARERA CM, GUARNIERI C, 1989. Opioid receptors in rat cardiac sarcelomma: effect of phenylephrine and isoproterenol. Biochim Biophys Acta 987: 69-74.
27. YTREHUS K, LIU Y, TSHUCHIDA A, MUIRA T, LIU GS, YANG X-M, HERBERT D, COHEN MV, DOWNEY JM, 1994. Rat and rabbit heart infection: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol 267: H2383-H2390.
28. ZHANG W-M, JIN W-Q, WONG TM, 1996. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma. J Mol Cell Cardiol 28: 1547-1554.
29. ZIMLICHMAN R, GEFEL D, ELIAHOU H, MATAS Z, ROSEN B, GASS S, ELA C, EILAM Y, VOGEL Z, BARG J, 1996. Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation 93: 1020-1025.